Losartan Potassium/Amlodipine Camsylate/Ezetimibe/Rosuvastatin Calcium

氯沙坦钾/樟脑磺酸氨氯地平/依折麦布/瑞舒伐他汀钙

Report date: 2026/02/03 10:08:05

Base Information

Drug NameLosartan Potassium/Amlodipine Camsylate/Ezetimibe/Rosuvastatin Calcium
Drug Alias NameAmosartan XQ
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockersNiemann-Pick C1-like protein 1 inhibitors +[5] 
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channelNiemann-Pick C1-like protein 1 +[4] 
Therapy Area/IndicationsDyslipidemiasHypertension
Global Approved IndicationsDyslipidemiasHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2020/11/09
Country/TerritorySouth Korea
CombinationsYes Losartan PotassiumAmlodipine CamsylateEzetimibe
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDyslipidemiasHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A